Insmed | Kortsiktig Gjeld

Current Liabilities Endring Dato
BioMarin Pharmaceutical USD 1.18B 13.8M 2023-12
Cytokinetics USD 102.68M 24.96M 2023-12
Dynavax Technologies USD 62.2M 7.93M 2023-12
Gilead Sciences USD 11.28B 665M 2023-12
Heron Therapeutics USD 79.74M 6.98M 2023-09
Insmed USD 225.63M 28.9M 2023-12
Regeneron Pharmaceuticals USD 4.4B 805.6M 2023-12
Sarepta Therapeutics USD 450.74M 47.91M 2023-09
Ultragenyx Pharmaceutical USD 253.98M 9.6M 2023-09
Vertex Pharmaceuticals USD 3.6B 247.3M 2023-09



Insmed Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.